サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768136

ランセットの世界市場

Lancets

出版日
ページ情報
英文 375 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
ランセットの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 375 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ランセットの世界市場は2030年までに66億米ドルに達する見込み

2024年に47億米ドルと推定されるランセットの世界市場は、2024年から2030年にかけてCAGR 5.7%で成長し、2030年には66億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである「セーフティ」は、CAGR 5.6%を記録し、分析期間終了時には28億米ドルに達すると予測されます。標準セグメントの成長率は、分析期間中CAGR 3.8％と推定されます。

米国市場は12億米ドルと推定、中国はCAGR 9.2％で成長予測

米国のランセット市場は、2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに16億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0％と4.4％と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界のランセット市場- 主要動向と促進要因のまとめ

ランセットは血液サンプリングと患者ケアにどのような革命をもたらしているか？

ランセットは、検査用の血液サンプルを採取するための小型医療機器であり、定期的な血糖値モニタリングが必要な糖尿病などの疾患の管理に不可欠です。ランセットは、皮膚への穿刺を素早く、低侵襲で行い、毛細血管の血液を採取できるように設計されています。長年にわたり、安全なランセットとシングルユース器具の開発により、採血に革命をもたらし、交差汚染や感染のリスクを減らすことにより、患者の安全性を向上させました。ランセットは、臨床現場と在宅ケアの両方で広く使用されており、ヘルスケアに欠かせないツールとなっています。

ランセット市場を形成している技術革新とは？

ランセットのデザインと機能性における技術的進歩は、安全性、快適性、使いやすさを向上させています。使用後に収納される安全性の高いランセットは、偶発的な針刺し事故を防ぎ、血液感染のリスクを低減するため、病院や診断ラボのような大量の医療現場で特に重宝されています。さらに、極細針技術の進歩により、ランセットは採血時の痛みを最小限に抑え、患者にとってより快適なものとなりました。デジタルヘルスと遠隔モニタリングの人気の高まりも、ランセットの設計革新を後押ししており、デバイスは現在、モバイルアプリと同期する血糖モニタリングシステムに統合され、患者がリアルタイムでデータを追跡できるようになっています。

市場セグメンテーションはランセットの成長をどのように定義するか？

種類には、セーフティ・ランセット、スタンダード・ランセット、スペシャリティ・テランセットがあり、セーフティ・ランセットは、感染管理のために病院や診療所で広く使用されているため、最大のセグメントを占めています。アプリケーションには、血糖値検査、コレステロール検査、ヘモグロビン検査、アレルギー検査などがあり、世界の糖尿病罹患率の上昇に伴い、血糖値検査が市場をリードしています。エンドユーザーには、病院、診療所、診断ラボ、在宅ケアの現場が含まれ、糖尿病のような慢性疾患を自宅で管理する患者の増加に伴い、在宅ケアが重要な成長分野となっています。

ランセット市場の成長を促進する要因とは？

ランセット市場の成長は、糖尿病有病率の上昇、在宅血糖モニタリングの需要増加、安全性と快適性機能の進歩など、いくつかの要因によってもたらされます。糖尿病の世界の負担増に伴い、定期的な血液検査の必要性がランセットの需要を促進しており、特に患者が便利で使いやすいデバイスを必要とする在宅ケア環境ではその傾向が顕著です。感染リスクを低減し、患者の快適性を向上させる安全性ランセットの技術革新は、市場の成長をさらに後押ししています。さらに、コレステロールやヘモグロビン検査など、さまざまな検査を行う診断ラボでのランセットの使用が増加していることも、市場を拡大しています。

セグメント

製品タイプ（セーフティ、スタンダード、スペシャリティ）、用途（血糖値検査、ヘモグロビン検査、コレステロール検査、凝固検査、その他用途）、最終用途（病院・診療所、在宅医療、その他最終用途）

調査対象企業の例

  • Arkray
  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • HTL-Strefa S.A
  • Owen Mumford
  • Roche Diagnostics
  • Sarstedt
  • Sterilance Medical（Suzhou）
  • Terumo Corporation
  • Ypsomed

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22136

Global Lancets Market to Reach US$6.6 Billion by 2030

The global market for Lancets estimated at US$4.7 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Standard segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Lancets market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Lancets Market - Key Trends and Drivers Summarized

How Are Lancets Revolutionizing Blood Sampling and Patient Care?

Lancets, small medical devices used to obtain blood samples for testing, are essential in managing conditions such as diabetes, where regular blood glucose monitoring is required. Lancets are designed to make quick and minimally invasive punctures on the skin, allowing for the collection of capillary blood. Over the years, the development of safety lancets and single-use devices has revolutionized blood sampling, improving patient safety by reducing the risk of cross-contamination and infection. Lancets are widely used in both clinical settings and home care, making them an indispensable tool in healthcare.

What Technological Innovations Are Shaping the Lancets Market?

Technological advancements in lancet design and functionality are enhancing their safety, comfort, and ease of use. Safety lancets, which retract after use, prevent accidental needle sticks and reduce the risk of bloodborne infections, making them particularly valuable in high-volume healthcare settings such as hospitals and diagnostic labs. Furthermore, advancements in ultra-thin needle technology have made lancets more comfortable for patients by minimizing pain during blood sampling. The growing popularity of digital health and remote monitoring is also driving innovations in lancet design, with devices now being integrated into blood glucose monitoring systems that sync with mobile apps, allowing patients to track their data in real time.

How Do Market Segments Define the Growth of Lancets?

Types include safety lancets, standard lancets, and specialty lancets, with safety lancets representing the largest segment due to their widespread use in hospitals and clinics for infection control. Applications include blood glucose testing, cholesterol testing, hemoglobin testing, and allergy testing, with blood glucose testing leading the market as the global incidence of diabetes continues to rise. End-users include hospitals, clinics, diagnostic labs, and home care settings, with home care becoming a key growth area as more patients manage chronic conditions like diabetes from the comfort of their homes.

What Factors Are Driving the Growth in the Lancets Market?

The growth in the lancets market is driven by several factors, including the rising prevalence of diabetes, increasing demand for home-based blood glucose monitoring, and advancements in safety and comfort features. As the global burden of diabetes grows, the need for regular blood testing is driving demand for lancets, particularly in home care settings where patients require convenient and easy-to-use devices. Technological innovations in safety lancets, which reduce the risk of infection and improve patient comfort, are further propelling market growth. Additionally, the increasing use of lancets in diagnostic labs for a variety of tests, including cholesterol and hemoglobin testing, is expanding the market.

SCOPE OF STUDY:

The report analyzes the Lancets market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Safety, Standard, Specialty); Application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing, Other Applications); End-Use (Hospitals & Clinics, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Arkray
  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • HTL-Strefa S.A
  • Owen Mumford
  • Roche Diagnostics
  • Sarstedt
  • Sterilance Medical (Suzhou)
  • Terumo Corporation
  • Ypsomed

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Lancets - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes and Need for Blood Glucose Monitoring Spurs Growth in Lancets Market
    • Technological Advancements in Safety and Painless Lancets Strengthen Business Case for Adoption
    • Growing Focus on Home Healthcare and Self-Monitoring Expands Addressable Market for Lancets
    • Expansion of Point-of-Care Testing and Diagnostic Devices Fuels Demand for Lancets
    • Rising Demand for Disposable and Single-Use Lancets in Clinical Settings Propels Market Growth
    • Technological Innovations in Needleless and Low-Pain Lancets Propel Market Expansion
    • Increasing Use of Lancets in Blood Sampling for Cholesterol and Hemoglobin Testing Expands Market Opportunities
    • Growing Focus on Patient Comfort and Safety Drives Demand for Advanced Lancet Solutions
    • Rising Adoption of Lancets in Pediatric and Geriatric Care Expands Market Potential
    • Focus on Reducing the Risk of Needlestick Injuries and Contamination Fuels Adoption of Safety Lancets
    • Technological Advancements in Lancets for Continuous Glucose Monitoring Propel Market Growth
    • Rising Use of Lancets in Home Diagnostics and Telehealth Services Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Blood Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Lancets Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Safety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Standard by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Standard by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Specialty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Specialty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Specialty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • JAPAN
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • CHINA
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • EUROPE
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Lancets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Lancets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • FRANCE
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • GERMANY
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Lancets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • INDIA
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Lancets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Lancets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Lancets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Lancets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030
  • AFRICA
    • Lancets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Lancets by Application - Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Lancets by Application - Percentage Breakdown of Value Sales for Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Lancets by End-Use - Home Care, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Lancets by End-Use - Percentage Breakdown of Value Sales for Home Care, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Lancets by Product Type - Safety, Standard and Specialty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Lancets by Product Type - Safety, Standard and Specialty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Lancets by Product Type - Percentage Breakdown of Value Sales for Safety, Standard and Specialty for the Years 2015, 2025 & 2030

IV. COMPETITION